Ptc Therapeutics (PTCT) Other Operating Expenses (2012 - 2026)

Ptc Therapeutics' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $40.5 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 4967.0% year-over-year to $40.5 million; the TTM figure through Mar 2026 stood at $40.5 million (up 683.3% YoY), while the FY2025 annual figure was $800000.0, down 82.12% from the prior year.
• Other Operating Expenses was $40.5 million for Q1 2026 at Ptc Therapeutics, up from $800000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $128.9 million in Q2 2023 to a low of -$6.3 million in Q4 2022.
• Historically, Other Operating Expenses has averaged $14.2 million across 5 years, with a median of $1.8 million in 2023.
• Biggest YoY gain for Other Operating Expenses was 11800.0% in 2022; the steepest drop was 152.07% in 2022.
• A 5-year view of Other Operating Expenses shows it stood at -$6.3 million in 2022, then soared by 142.86% to $2.7 million in 2023, then surged by 276.85% to $10.2 million in 2024, then slumped by 92.14% to $800000.0 in 2025, then soared by 4967.0% to $40.5 million in 2026.
• The last three Other Operating Expenses figures came in at $40.5 million (Q1 2026), $800000.0 (Q1 2025), and $10.2 million (Q4 2024), per Business Quant data.